Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Diseases × Prostate-Specific Antigen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Prostatic Hyperplasia 1 Prostatic Diseases 1 Neoplasms 1

Interventions

padeliporfin 2 sipuleucel-T 1 luprolide acetate gel depot 1 apalutamide 1 Therapeutics 1 Tamsulosin 1 Prostate-Specific Antigen 1 Microtubule-Associated Proteins 1 Leuprolide 1 Imatinib Mesylate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00853710 2025-11-20

Test Semiquantitative Prostate Specific Antigen (PSA)

Institut Curie

Phase NA Completed

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡